Ligand validation:6YC0

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6YC0_OLC_C_301	29%	50%	0.206	0.892	1.01	0.92	1	1	1	84%	0.84
6YC0_OLC_A_313	28%	49%	0.199	0.897	1.08	0.91	1	-	3	76%	0.76
6YC0_OLC_C_303	22%	53%	0.221	0.88	1.02	0.82	1	-	2	76%	0.76
6YC0_OLC_D_312	22%	48%	0.23	0.882	1.08	0.93	1	1	0	80%	0.8
6YC0_OLC_B_302	19%	88%	0.158	0.894	0.26	0.4	-	-	0	20%	0.2
6YC0_OLC_A_316	17%	50%	0.231	0.862	1.05	0.87	1	1	0	72%	0.72
6YC0_OLC_A_302	16%	47%	0.254	0.886	1.15	0.91	1	-	1	68%	0.68
6YC0_OLC_E_407	15%	43%	0.222	0.853	1.2	1	1	2	1	60%	0.6
6YC0_OLC_D_301	12%	88%	0.194	0.862	0.26	0.41	-	-	0	20%	0.2
6YC0_OLC_B_301	11%	48%	0.244	0.823	1.12	0.88	1	1	0	64%	0.64
6YC0_OLC_C_315	11%	43%	0.229	0.807	1.17	1.06	1	1	1	64%	0.64
6YC0_OLC_D_304	10%	42%	0.292	0.871	1.24	1	1	2	0	56%	0.56
6YC0_OLC_E_406	9%	49%	0.261	0.79	1.05	0.92	1	1	0	80%	0.8
6YC0_OLC_A_301	8%	82%	0.219	0.809	0.32	0.47	-	-	0	36%	0.36
6YC0_OLC_B_303	8%	41%	0.3	0.862	1.29	1	1	1	0	48%	0.48
6YC0_OLC_C_307	7%	44%	0.253	0.781	1.16	0.99	1	1	3	64%	0.64
6YC0_OLC_A_305	7%	43%	0.271	0.803	1.21	1	1	1	0	60%	0.6
6YC0_OLC_A_314	6%	49%	0.338	0.804	1.07	0.92	1	1	1	80%	0.8
6YC0_OLC_D_303	5%	88%	0.237	0.8	0.31	0.36	-	-	0	20%	0.2
6YC0_OLC_C_304	5%	78%	0.272	0.801	0.35	0.53	-	-	0	32%	0.32
6YC0_OLC_D_302	4%	45%	0.337	0.781	1.1	1.01	1	1	0	72%	0.72
6YC0_OLC_E_405	4%	83%	0.24	0.689	0.26	0.52	-	-	0	64%	0.64
6YC0_OLC_C_302	3%	50%	0.283	0.664	1.04	0.91	1	2	1	80%	0.8
6YC0_OLC_E_404	2%	85%	0.304	0.715	0.25	0.48	-	-	0	32%	0.32
6YC0_OLC_C_305	2%	41%	0.407	0.757	1.29	1	1	1	0	48%	0.48
6YC0_OLC_A_304	2%	39%	0.433	0.762	1.31	1.08	1	1	0	52%	0.52
6YC0_OLC_A_303	1%	82%	0.425	0.759	0.35	0.44	-	-	0	28%	0.28
6YC0_OLC_C_306	1%	29%	0.486	0.734	1.91	0.96	2	1	0	68%	0.68
6YC1_OLC_D_308	48%	43%	0.122	0.943	1.23	0.98	1	2	0	56%	0.56
6RF3_OLC_D_307	43%	41%	0.123	0.924	1.24	1.05	1	2	0	56%	0.56
6YC3_OLC_D_307	40%	44%	0.149	0.937	1.21	0.95	1	2	0	56%	0.56
6RF4_OLC_B_301	39%	50%	0.16	0.886	1	0.92	1	1	4	88%	0.88
6RFC_OLC_A_328	30%	56%	0.176	0.839	0.91	0.78	1	1	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6YC0

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate